Ophthalmology Risk Minimisation Materials

EYLEA® (aflibercept)

Close-up-eye

Here you can find links to the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for EYLEA® (aflibercept), via the Electronics Medicines Compendium (eMC), a resource providing information about all medicines available in the UK. Please note that this information is specific to Great Britain and is not intended to replace the advice of a qualified doctor. For more information on EYLEA or any related support, please contact the Bayer Medical Information team on 0118 206 3116, or email medical.information@bayer.co.uk.

 

EYLEA 8 mg Summary of Product Characteristics

EYLEA 8 mg Patient Information Leaflet

 

EYLEA 2 mg Summary of Product Characteristics

EYLEA 2 mg Patient Information Leaflet

Prescriber guide

Prescriber guide video

Prescribing information for EYLEA® (aflibercept) can be found here.

EYLEA patient guides

All patient guides are recertified for use with original date of preparation.


Your guide to EYLEA
Wet age-related macular degeneration (wAMD)
EYLEA® (aflibercept) 8 mg
Discover data and resources about EYLEA 8 mg
PP-EYL-GB-2321, September 2024
HCP Resources
Access useful, downloadable ophthalmology resources for HCPs
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg

PP-EYL-GB-2344 | August 2024